1Bystanders or not? Microglia and lymphocytes in aging and strokeJustin N.Nguyen，Anjali ChauhanReviews1397-1403
2Alzheimer's disease risk after COVID-19: a view from the perspective of the infectious hypothesis of neurodegenerationEugenia Olivera，Albany Sáez，Lila Carniglia，Carla Caruso，Mercedes Lasaga，Daniela DurandReviews1404-1410
3Serine and arginine rich splicing factor 1: a potential target for neuroprotection and other diseasesAna M.Sandoval-Castellanos，Anushka Bhargava，Min Zhao，Jun Xu，Ke NingReviews1411-1416
4Can glial cells save neurons in epilepsy?Weida Shen，Jelena Bogdanovi? Pristov，Paola Nobili，Ljiljana Nikoli?Reviews1417-1422
5Lights for epilepsy: can photobiomodulation reduce seizures and offer neuroprotection?Napoleon Torres-Martinez，Stephan Chabardes，John MitrofanisReviews1423-1426
6The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosisIlaria Martinelli，Elisabetta Zucchi，Cecilia Simonini，Giulia Gianferrari，Giovanna Zamboni，Marcello Pinti，Jessica MandrioliReviews1427-1433
7CMT1A current gene therapy approaches and promising biomarkersMarina Stavrou，Kleopas A.KleopaReviews1434-1440
8Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surfaceDan-Dan Liu，Chao-Yang Zhang，Jing-Ting Zhang，Li-Min Gu，Guo-Tong Xu，Jing-Fa ZhangReviews1441-1449
9Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson's diseaseTamara Andrea Alarcón，Sarah Martins Presti-Silva，Ana Paula Toniato Sim?es，Fabiola Mara Ribeiro，Rita Gomes Wanderley PiresReviews1450-1456
10Regulation of enolase activation to promote neural protection and regeneration in spinal cord injuryHannah M.McCoy，Rachel Polcyn，Naren L.Banik，Azizul HaqueReviews1457-1462
11Converging links between adult-onset neurodegenerative Alzheimer's disease and early life neurodegenerative neuronal ceroid lipofuscinosis?Marcel Klein，Guido HermeyReviews1463-1471
12Mitochondria in Huntington's disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategiesAnamaria Jurcau，Carolina Maria JurcauReviews1472-1477
13Stem cell therapy in retinal diseasesAudrey Voisin，Amaury Pénaguin，Afsaneh Gaillard，Nicolas LevezielReviews1478-1485
14Overcoming mitochondrial dysfunction in neurodegenerative diseasesJo?o Pessoa，Ana I.DuartePerspectives1486-1488
15Functional hyperconnectivity related to brain disease: maladaptive process or element of resilience?Markus Aswendt，Mathias HoehnPerspectives1489-1490
16Aquaporin 5 in Alzheimer's disease: a link between oral and brain pathology?Cristina Municio，Eva CarroPerspectives1491-1492
17Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?Jorge Pascual-Guerra，José A.Rodríguez-Navarro，Carlos L.PaínoPerspectives1493-1494
18Pemafibrate, a potent selective peroxisome proliferator-activated receptor α modulator, a promising novel treatment for ischemic retinopathy?Deokho Lee，Yohei Tomita，Kazuno Negishi，Toshihide KuriharaPerspectives1495-1496
19From dolphins to dogs: new opportunities to understand the role of P2X4 receptors in spinal cord injury and neuropathic painReece A.Sophocleous，Ronald SluyterPerspectives1497-1498
20Mutations in Hevin/Sparcl1 and risk of autism spectrum disorderTakumi Taketomi，Fuminori TsurutaPerspectives1499-1500
